Establishment Labs Holdings financials
$63.70−2.51%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $211.1M | $166.0M | $165.2M | $161.7M | $126.7M | $84.7M | $89.6M | $61.2M |
| Gross profit | $146.3M | $109.5M | $107.0M | $106.6M | $85.4M | $52.5M | $54.9M | $36.1M |
| Gross margin | 69.3% | 66.0% | 64.8% | 65.9% | 67.4% | 62.0% | 61.3% | 59.0% |
| Operating income | -$39.0M | -$50.0M | -$65.0M | -$39.7M | -$25.1M | -$27.9M | -$30.7M | -$25.6M |
| Net income | -$51.1M | -$84.6M | -$78.5M | -$75.2M | -$41.1M | -$38.1M | -$38.1M | -$21.1M |
| Net margin | −24.2% | −51.0% | −47.5% | −46.5% | −32.5% | −45.0% | −42.6% | −34.5% |
| Diluted EPS | $-1.72 | $-3.00 | $-3.07 | $-3.08 | $-1.72 | $-1.63 | $-1.86 | $-1.22 |
| EBITDA | -$29.4M | -$43.2M | -$60.9M | -$35.8M | -$21.0M | -$24.6M | -$27.7M | -$21.1M |
| Operating cash flow | -$50.9M | -$58.5M | -$88.5M | -$52.2M | -$27.5M | -$12.2M | -$29.7M | -$35.6M |
| Free cash flow | -$56.9M | -$67.0M | -$111.7M | -$85.5M | -$32.8M | -$14.6M | -$36.0M | -$37.3M |
| Diluted shares | 29.6M | 28.2M | 25.6M | 24.5M | 24.0M | 23.3M | 20.5M | 17.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $75.6M | $90.3M | $40.0M | $66.4M | $53.4M | $84.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $247.5M | $219.6M | $188.7M | $175.5M | $51.9M | $49.8M |
| Total assets | $357.2M | $346.8M | $268.6M | $211.1M | $139.5M | $156.4M |
| Total liabilities | $333.6M | $293.7M | $250.2M | $219.2M | $88.8M | $81.4M |
| Shareholders' equity | $23.5M | $53.1M | $18.4M | -$8.2M | $50.7M | $75.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology